Human Granulocyte Colony Stimulating Factor (rH-GCSF) stimulates production of white blood cells.
Pegylated Human Granulocyte Colony Stimulating Factor (rH-PEG-GCSF) is a long acting version of rH-GCSF.
GCSFs are used for treating neutropenia conditions related to chemotherapy, and increase the number of hematopoietic stem cells in the blood of donors.
Both products are manufactured in a cGMP state of the art EU/FDA approvable facility based on rDNA technology from E.coli cells.
GCSFs products are tested against the reference product for clinical evaluation.
rH-GCSF is available in syringe of 300 mcg/0.5ml.
rH-PEG-GCSF is available in syringe of 6 mg/0.6 ml.
Both products are available in bulk ABS form for compounding and filling in third parties facilities.